ES437505A1 - Procedure for obtaining morpholine derivatives. (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure for obtaining morpholine derivatives. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES437505A1
ES437505A1 ES437505A ES437505A ES437505A1 ES 437505 A1 ES437505 A1 ES 437505A1 ES 437505 A ES437505 A ES 437505A ES 437505 A ES437505 A ES 437505A ES 437505 A1 ES437505 A1 ES 437505A1
Authority
ES
Spain
Prior art keywords
formula
radical
compound
those compounds
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES437505A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2001374A external-priority patent/GB1452701A/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES437505A1 publication Critical patent/ES437505A1/en
Expired legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedure for obtaining morpholine derivatives, of the formula: **(See formula)** wherein A represents an ethylene (-CH2CH2-) or vinylene (-CH = CH-) radical and X represents a phenyl radical optionally substituted by one or two substituents selected from the group consisting of halogen atoms, alkoxy radicals from 1 to 6 carbon atoms and radicals of 6 to 10 carbon atoms, said aryloxy radicals in turn being optionally substituted by one or two substituents selected from the group consisting of halogen atoms and alkyl radicals of 1 to 4 carbon atoms, and the salts of Pharmaceutically acceptable addition acids thereof, characterized in that it comprises: (a) replacing the radical R1 with hydrogen in a compound of the formula: **(See formula)** wherein R1 is an optionally substituted alkanoyl or alkoxycarbonyl radical of up to 6 carbon atoms, an aroyl, an arylalkyl or aryloxycarbonyl radical of up to 11 carbon atoms or a cyano radical; (b) for those compounds in which A is an ethylene radical, reduce a compound of the formula: **(See formula)** with hydrogen in the presence of a catalyst; (o) for those compounds in which, A is a vinylidene radical, dehydrate a compound of formula: **(See formula)** (d) for those compounds in which A is an ethylene radical, react a compound of formula IV with hydrogen in the presence of a catalyst; (e) cyclizing a compound of the formula: X - A -CHOH.CH2.NH.CH2CH2 - Z wherein Z represents a displaceable halogen atom or sulfonyloxy radical, in the presence of a base; (f) reduce a compound of formula: **(See formula)** (g) for those compounds in which A is an ethylene radical, desulfurize a compound of formula: **(See formula)** (h) for those compounds in which A is a transvinylene radical, isomerize a compound of formula: **(See formula)** (i) for those compounds in which A is a vinyl radical, remove the hydrogen and halogen elements from a compound of formula: **(See formula)** where Y is a halogen atom; or (j) for a compound that is an optically active enantiomer, redissolution of the racemic compound of formula I by conventional means, or by using procedures (a) to (i) in which the intermediate of formulas II, III, IV, V, VI, VII, VIII or IX is a dissolved isomer. (Machine-translation by Google Translate, not legally binding)
ES437505A 1974-05-07 1975-05-07 Procedure for obtaining morpholine derivatives. (Machine-translation by Google Translate, not legally binding) Expired ES437505A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2001374A GB1452701A (en) 1974-05-07 1974-05-07 Morpholine derivatives

Publications (1)

Publication Number Publication Date
ES437505A1 true ES437505A1 (en) 1977-01-01

Family

ID=10138905

Family Applications (2)

Application Number Title Priority Date Filing Date
ES437505A Expired ES437505A1 (en) 1974-05-07 1975-05-07 Procedure for obtaining morpholine derivatives. (Machine-translation by Google Translate, not legally binding)
ES454182A Expired ES454182A1 (en) 1974-05-07 1976-12-13 Procedure for the obtaining of morpholine derivatives. (Machine-translation by Google Translate, not legally binding)

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES454182A Expired ES454182A1 (en) 1974-05-07 1976-12-13 Procedure for the obtaining of morpholine derivatives. (Machine-translation by Google Translate, not legally binding)

Country Status (8)

Country Link
ES (2) ES437505A1 (en)
IE (1) IE40987B1 (en)
IL (1) IL47112A (en)
MY (1) MY8100016A (en)
NO (1) NO138407C (en)
PH (1) PH15231A (en)
SU (1) SU585815A3 (en)
YU (3) YU115375A (en)

Also Published As

Publication number Publication date
IL47112A0 (en) 1975-06-25
PH15231A (en) 1982-10-01
YU193381A (en) 1982-02-28
IE40987L (en) 1975-11-07
SU585815A3 (en) 1977-12-25
NO138407B (en) 1978-05-22
ES454182A1 (en) 1977-12-01
IE40987B1 (en) 1979-09-26
NO138407C (en) 1978-08-30
YU115375A (en) 1982-02-28
YU193481A (en) 1982-02-28
NO751621L (en) 1975-11-10
MY8100016A (en) 1981-12-31
IL47112A (en) 1977-12-30

Similar Documents

Publication Publication Date Title
SE7702609L (en) AMINOAL COOLETHEROCYCLES
ES467288A1 (en) N-(substituted-aminoalkyl)-2-oxo-1-pyrrolidineacetamides
ES403503A1 (en) Procedure for the preparation of piperidine derivatives and their use as stabilizers (Machine-translation by Google Translate, not legally binding)
ES464747A1 (en) Tetralines
ES8203845A1 (en) Pyridoxine derivatives, process for their preparation and their therapeutical use.
SE432253B (en) ANALOGY PROCEDURE FOR PREPARING 8ALFA-ERGOLIN-I DERIVATIVES
ES469953A1 (en) Novel aminoalkylbenzene derivative process for preparing same medical composition and application thereof
PE20010750A1 (en) SPIRO DERIVATIVES [2H-1-BENZOPYRAN-2,4`-PIPERIDINE]
PE20050160A1 (en) 3-AMINOPYRROLIDINES AS INHIBITORS OF MONOAMINE UPTAKE
ES443563A1 (en) 2-methoxy-benzamide derivatives
ES437505A1 (en) Procedure for obtaining morpholine derivatives. (Machine-translation by Google Translate, not legally binding)
ES530503A0 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 4-BENZALQUILAMIDO-2-CARBALCOXIFENOXIAMINO-PROPANOL.
DE3060198D1 (en) Esters of allethrolone derivatives and carboxylic acids, process for their preparation and the compositions containing them
ES516554A0 (en) PROCEDURE FOR PREPARING NEW DERIVATIVES OF ETHENYLIMIDAZOLE.
NO173276C (en) Analogous Process for Preparing Therapeutically Active 1,4-Disubstituted-Piperidinyl Derivatives
HUT35253A (en) Process for preparing 4-/3-alkynyl-oxy-2-hydroxy-propyl/-piperazin-1-y1-n-phenyl-acetamide derivatives
FR2476649B1 (en)
ES316528A1 (en) Procedure for preparing agents to combat parasites. (Machine-translation by Google Translate, not legally binding)
ES422085A1 (en) Primary amino acylanilides methods of making the same and use as antiarrhythmic drugs
ES419195A1 (en) Benzoisoindoline derivatives
LV10244A (en) New aralkylamine derivatives as a means of obtaining and using medicine
ES475122A1 (en) A procedure for the preparation of new derivatives of 4-amino-2-piperidino-quinazolina. (Machine-translation by Google Translate, not legally binding)
ES421073A3 (en) A method for preparing quinoxalinadi-N-oxides. (Machine-translation by Google Translate, not legally binding)
ES417269A1 (en) 3-azetidinylethyl-1-phenyl-2-midazolidinone derivatives
ES440491A1 (en) Procedure for obtaining new esters of antranilic acid and N-substitute antranilic acids. (Machine-translation by Google Translate, not legally binding)